(Q40325245)

19 September 2017

title

Cleavage of intracellular hepatitis C RNA in the virus core protein coding region by deoxyribozymes (English)

1 reference

19 September 2017

Trepanier J

1

1 reference

19 September 2017

Tanner JE

2

1 reference

19 September 2017

Momparler RL

3

1 reference

19 September 2017

Le ON

4

1 reference

19 September 2017

Alvarez F

5

1 reference

19 September 2017

Alfieri C

6

1 reference

19 September 2017

publication date

1 February 2006

1 reference

Journal of Viral Hepatitis

19 September 2017

published in

1 reference

19 September 2017

volume

13

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

131-138

1 reference

Course and outcome of hepatitis C

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Clinical significance of hepatitis C virus genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Hepatitis C virus therapies: current treatments, targets and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Inhibition of hepatitis C virus-directed gene expression by a DNA ribonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

The hairpin ribozyme. Discovery, mechanism, and development for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Nucleic-acid therapeutics: basic principles and recent applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

21 January 2018

Ribozyme therapeutics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Engineered catalytic RNA and DNA : new biochemical tools for drug discovery and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Sequence specific cleavage of the HIV-1 coreceptor CCR5 gene by a hammer-head ribozyme and a DNA-enzyme: inhibition of the coreceptor function by DNA-enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Comparative study of DNA enzymes and ribozymes against the same full-length messenger RNA of the vanilloid receptor subtype I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

A general purpose RNA-cleaving DNA enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Sequence-specific cleavage of Huntingtin mRNA by catalytic DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Inhibition of HIV-1 gene expression by novel DNA enzymes targeted to cleave HIV-1 TAR RNA: potential effectiveness against all HIV-1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Inhibition of hepatitis B virus X gene expression by novel DNA enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

A new modified DNA enzyme that targets influenza virus A mRNA inhibits viral infection in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Mfold web server for nucleic acid folding and hybridization prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Mechanism and utility of an RNA-cleaving DNA enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Inhibition of infection of incoming HIV-1 virus by RNA-cleaving DNA enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

RNA accessibility prediction: a theoretical approach is consistent with experimental studies in cell extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Design of nuclease resistant protein kinase calpha DNA enzymes with potential therapeutic application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

DNA ribonucleases that are active against intracellular hepatitis B viral RNA targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Predicting the therapeutic response in patients with chronic hepatitis C: the role of viral kinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Mechanisms of drug resistance and novel approaches to therapy for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Secondary structure and hybridization accessibility of hepatitis C virus 3'-terminal sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

In vivo application of non-viral vectors to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Antisense technologies. Improvement through novel chemical modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

Nucleic acid based strategies as potential therapeutic tools: mechanistic considerations and implications to restenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

The influence of arm length asymmetry and base substitution on the activity of the 10-23 DNA enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00684.X

10.1111/J.1365-2893.2005.00684.X

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference